InMed Pharmaceuticals Inc (INM) financials · rev $4.9M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
InMed Pharmaceuticals Inc (INM) rev $4.9M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $4.94M | $4.60M |
| Cost of Revenue | $3.24M | $3.50M |
| Gross Profit | $1.71M | $1.10M |
| Net Income | -$8.16M | -$7.68M |
| EPS (Diluted) | -$8.36 | -$1.01 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $15.6M | $11.8M |
| Current Assets | $12.9M | $8.69M |
| Cash & Equivalents | $11.1M | $6.57M |
| Inventory | $961.2K | $1.24M |
| PP&E | $992.2K | $1.25M |
| Total Liabilities | $2.15M | $2.62M |
| Current Liabilities | $1.84M | $1.97M |
| Shareholders' Equity | $13.4M | $9.21M |
| Retained Earnings | -$117.2M | -$109.1M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$7.77M | -$6.99M |
| CapEx | N/A | $9.29K |
| Investing Cash Flow | N/A | -$9.29K |
| Financing Cash Flow | $12.3M | $4.65M |
| Net Change in Cash | N/A | -$2.34M |
| Free Cash Flow | -$7.77M | -$7.00M |
FAQ
What is INM P/E and revenue?
InMed Pharmaceuticals Inc (INM) rev $4.9M.
What is INM revenue?
InMed Pharmaceuticals Inc last cached revenue is $4.94M (FY2025).
Is INM profitable?
InMed Pharmaceuticals Inc last cached net income is -$8.16M (FY2025).
What are INM total assets?
InMed Pharmaceuticals Inc last cached total assets are $15.6M (FY2025).
What is INM free cash flow?
InMed Pharmaceuticals Inc last cached free cash flow is -$7.77M (FY2025).
Not investment advice. Cached statements, not a live tape.